[go: up one dir, main page]

NL8101114A - Inwendige zouten van sulfo-oxytriaziniumhydroxyde, sulfo-oxypyrimidiniumhydroxyde en sulfo-oxypyridiniumhydroxyde, werkwijze voor het bereiden daarvan, alsmede daaruit bereide c.q. vervaardigde farmaceutische preparaten. - Google Patents

Inwendige zouten van sulfo-oxytriaziniumhydroxyde, sulfo-oxypyrimidiniumhydroxyde en sulfo-oxypyridiniumhydroxyde, werkwijze voor het bereiden daarvan, alsmede daaruit bereide c.q. vervaardigde farmaceutische preparaten. Download PDF

Info

Publication number
NL8101114A
NL8101114A NL8101114A NL8101114A NL8101114A NL 8101114 A NL8101114 A NL 8101114A NL 8101114 A NL8101114 A NL 8101114A NL 8101114 A NL8101114 A NL 8101114A NL 8101114 A NL8101114 A NL 8101114A
Authority
NL
Netherlands
Prior art keywords
hydroxide
sulfooxy
amino
group
internal salt
Prior art date
Application number
NL8101114A
Other languages
English (en)
Dutch (nl)
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NL8101114A publication Critical patent/NL8101114A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/70—Other substituted melamines

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NL8101114A 1980-03-10 1981-03-09 Inwendige zouten van sulfo-oxytriaziniumhydroxyde, sulfo-oxypyrimidiniumhydroxyde en sulfo-oxypyridiniumhydroxyde, werkwijze voor het bereiden daarvan, alsmede daaruit bereide c.q. vervaardigde farmaceutische preparaten. NL8101114A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/128,995 US4287338A (en) 1980-03-10 1980-03-10 Sulfooxy-pyrimidinium, -pyridinium, and -triazinium hydroxide inner salts
US12899580 1980-03-10

Publications (1)

Publication Number Publication Date
NL8101114A true NL8101114A (nl) 1981-10-01

Family

ID=22437996

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8101114A NL8101114A (nl) 1980-03-10 1981-03-09 Inwendige zouten van sulfo-oxytriaziniumhydroxyde, sulfo-oxypyrimidiniumhydroxyde en sulfo-oxypyridiniumhydroxyde, werkwijze voor het bereiden daarvan, alsmede daaruit bereide c.q. vervaardigde farmaceutische preparaten.

Country Status (15)

Country Link
US (1) US4287338A (fi)
JP (1) JPS56150066A (fi)
AU (1) AU536166B2 (fi)
BE (1) BE887850A (fi)
CA (1) CA1154761A (fi)
CH (1) CH645626A5 (fi)
DE (1) DE3107583A1 (fi)
FI (1) FI70410C (fi)
FR (1) FR2477541A1 (fi)
GB (1) GB2071092B (fi)
HK (1) HK98088A (fi)
IT (1) IT1142667B (fi)
NL (1) NL8101114A (fi)
SE (1) SE448876B (fi)
ZA (1) ZA811057B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514672A (en) * 1981-02-17 1996-05-07 Bazzano; Gail S. Use of retinoids and compositions containing same for hair growth
US5183817A (en) * 1981-02-17 1993-02-02 Bazzano Gail S Combinations of retinoids and minoxidil-type compounds for hair growth
US4532240A (en) * 1982-09-09 1985-07-30 Warner-Lambert Company Diaminopyrimidines
WO1986004231A1 (en) * 1985-01-25 1986-07-31 The Upjohn Company Pyrimidine sulfates for hair growth
FR2590897B1 (fr) * 1985-12-06 1988-02-19 Kemyos Bio Medical Research Sr Nouveaux derives de 6 amino 1,2-dihydro-1-hydroxy-2-imino-pyrimidine, leur procede de preparation et compositions cosmetiques les renfermant
US4927626A (en) * 1988-10-28 1990-05-22 Devillez Richard L Method for enhancement of unguis growth
FR2651122B1 (fr) * 1989-08-29 1994-10-28 Oreal Compositions destinees a etre utilisees pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives de l'amino-2 pyrimidine oxyde-3 et nouveaux composes derives de l'amino-2 pyrimidine oxyde-3.
GB8929022D0 (en) * 1989-12-22 1990-02-28 Ici Plc Diazine derivatives
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
DE69108402T2 (de) * 1990-11-14 1995-10-05 Upjohn Co 5-fluor-2,4,6-pyrimidinthiaminderivate zur verhinderung des haarsausfalls.
FR2671082B1 (fr) * 1990-12-28 1993-04-16 Oreal Agent a plusieurs composants ou kit de preparation de la forme sulfo-conjuguee de composes pyrimidino- ou triazino-n-oxyde et procede de mise en óoeuvre.
FR2677884B1 (fr) * 1991-06-20 1993-07-09 Oreal Composition pour freiner la chute des cheveux a base de pyrimidines n-oxyde trisubstitues ou leurs derives sulfoconjugues, nouveaux composes pyrimidines n-oxyde ou leurs derives sulfoconjugues.
AU8681498A (en) 1997-08-01 1999-02-22 Reilly Industries, Inc. Supernucleophilic 4-substituted-pyridine catalysts, and processes useful for preparing same
EP1850663A4 (en) * 2005-02-22 2008-03-19 Cedars Sinai Medical Center USE OF MINOXIDILSULFATE AS AN ACTIVE AGAINST CANCER
TW200904437A (en) * 2007-02-14 2009-02-01 Janssen Pharmaceutica Nv 2-aminopyrimidine modulators of the histamine H4 receptor
EP2144877A1 (en) * 2007-04-04 2010-01-20 UCB Pharma, S.A. Novel pyridine derivatives, processes for preparing them, pharmaceutical compositions thereof
US8470833B2 (en) 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Hair growth and/or regrowth compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3270014A (en) * 1965-07-01 1966-08-30 Upjohn Co 1, 2-dihydro-1-hydroxy-1, 3, 5-triazines
US3382248A (en) * 1965-11-01 1968-05-07 Upjohn Co 6-amino-4, 5-di(substituted amino)-1, 2-dihydro-1-hydroxy-2-iminopyrimidines
US3464987A (en) * 1966-02-21 1969-09-02 Upjohn Co 1,2-dihydro-1-hydroxy-2-imino-6-(lower alkyl)pyrimidines
US3973016A (en) * 1974-08-05 1976-08-03 Warner-Lambert Company Blood pressure reducing hydroxypyrimidines
US4021562A (en) * 1975-12-08 1977-05-03 Mead Johnson & Company 4-Tertiary-amino-2,6-diaminopyridine 1-oxides

Also Published As

Publication number Publication date
GB2071092B (en) 1983-09-07
GB2071092A (en) 1981-09-16
FI70410C (fi) 1986-09-19
FR2477541A1 (fr) 1981-09-11
AU536166B2 (en) 1984-04-19
IT1142667B (it) 1986-10-15
FI70410B (fi) 1986-03-27
DE3107583C2 (fi) 1989-11-02
BE887850A (fr) 1981-09-09
JPS56150066A (en) 1981-11-20
SE8101421L (sv) 1981-09-11
CA1154761A (en) 1983-10-04
DE3107583A1 (de) 1982-01-07
FI810681L (fi) 1981-09-11
HK98088A (en) 1988-12-09
US4287338A (en) 1981-09-01
CH645626A5 (de) 1984-10-15
AU6737181A (en) 1981-09-17
IT8147976A0 (it) 1981-03-09
FR2477541B1 (fi) 1984-06-01
SE448876B (sv) 1987-03-23
JPH0145467B2 (fi) 1989-10-03
ZA811057B (en) 1982-03-31

Similar Documents

Publication Publication Date Title
NL8101114A (nl) Inwendige zouten van sulfo-oxytriaziniumhydroxyde, sulfo-oxypyrimidiniumhydroxyde en sulfo-oxypyridiniumhydroxyde, werkwijze voor het bereiden daarvan, alsmede daaruit bereide c.q. vervaardigde farmaceutische preparaten.
AU2019201179B2 (en) Therapeutically active compounds and their methods of use
DE69518841T2 (de) Corticotropinfreisetzungsfaktor antagonisten
EP0055583B1 (en) Antihypertensives
OA11492A (en) HIV inhibiting pyrimidine derivatives.
CN110418789A (zh) 作为治疗剂的N-环烷基/杂环烷基-4-(咪唑并[1,2-a]吡啶)嘧啶-2-胺的衍生物
DK150142B (da) Analogifremgangsmaade til fremstilling af 5-(2-imidazolin-2-yl)-aminopyrimidiner eller syreadditionssalte deraf
CA2512646A1 (en) 2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation
AU2010291318A1 (en) Novel pyrimidine and triazine hepcidine antagonists
HU225270B1 (en) 2,4-diamino-1,3,5-triazine derivatives, process for their preparation, their use for the preparation of pharmaceutical compositions and the pharmaceutical compositions containing them
CA2581623A1 (en) Novel pyridine compounds, process for their preparation and compositions containing them
JP2011516555A (ja) タンパク質キナーゼ阻害剤としての化合物および組成物
WO2004080981A1 (de) Pyrimidin-2-on-verbindungen und ihre verwendung als dopamin-d3-rezeptorliganden
EP1110952A1 (de) Neue Carbonsäurederivate, ihre Herstellung und Verwendung
AU2018361276B2 (en) P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof
DK160492B (da) Pyrimidinderivater, fremgangsmaader til fremstilling heraf samt farmaceutiske praeparater indeholdende disse derivater
FI55194C (fi) Foerfarande foer framstaellning av 6-substituerade 4-amino-1,2-dihydro-1-hydroxi-2-iminopyrimidiner
Dolzhenko et al. Synthesis of 5, 7-Diamino [1, 2, 4] triazolo [1, 2-a][1, 3, 5] triazines via Annulation of 1, 3, 5-Triazine Ring onto 3 (5)-Amino-1, 2, 4-trizoles
AU2021218497A1 (en) Quinolyl phosphine oxide compound, and composition and application thereof
JP3025239B2 (ja) ２，５−ジ置換ピリジンの製造方法
Hirota et al. Novel ring transformations of 5-cyanouracils into 2-thiocytosines, 2, 4-diaminopyrimidines, and pyrimido [4, 5-d] pyrimidines by the reaction with thioureas and guanidines
ZA200006044B (en) HIV inhibiting pyrimidine derivatives.
Trantolo et al. Inhibitors of Bacillus subtilis DNA polymerase III. Influence of modifications in the pyrimidine ring of anilino-and (benzylamino) pyrimidines
US2519715A (en) 1-carbamyl-4-heterocyclopiperazines
EP2231161A1 (en) A process of making imatinib

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed